SCHEMBL10686284

SCHEMBL10686284

Cc1cc(=O)c(C(=O)O)c(C)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.45
KDM4E B2RXH2 5/20 0.41
HPGD P15428 3/20 0.41
GAA P10253 2/20 0.41
HSD17B10 Q99714 2/20 0.41
DAO P14920 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
GPR35 Q9HC97 1/20 0.38
CYP1A2 P05177 1/20 0.37
ALDH1A1 P00352 5/20 0.37
ADORA1 P30542 1/20 0.36
ESR1 P03372 1/20 0.36
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35
BLM P54132 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CA1 P00915 1/20 0.35
CYP3A4 P08684 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3188766 0.83 CYP1A2 (0.45) KDM4EHPGDGAAHSD17B10CYP1A2
SCHEMBL9454351 0.82 CCNC (0.37) KDM4EHPGDGAAHSD17B10CYP1A2
SCHEMBL3175489 0.80 ALDH1A1 (0.43) HPGDGAACYP1A2ALDH1A1SMN1; SMN2
SCHEMBL9455203 0.79 ALDH1A1 (0.50) KDM4EHPGDGAAHSD17B10CYP1A2
SCHEMBL15570057 0.77 FABP3 (0.39) NOTUMKDM4EHPGDGAAHSD17B10
SCHEMBL13531552 0.76 ALDH1A1 (0.50) KDM4EHPGDHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL3189642 0.76 ALDH1A1 (0.61) KDM4EHPGDGAAHSD17B10CYP1A2
SCHEMBL10685631 0.75 MAPT (0.58) KDM4EHPGDGAAALDH1A1
SCHEMBL23147412 0.73 ALDH1A1 (0.40) NOTUMKDM4EHPGDGAAHSD17B10
SCHEMBL3192305 0.73 NPSR1 (0.46) KDM4EHPGDGAAHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12371428-B2 Pyridone compounds and methods of use EXELIXIS, INC. (US) 2025-07-29 US disclosed
US-20220315579-A1 PYRIDONE COMPOUNDS AND METHODS OF USE EXELIXIS, INC. 2022-10-06 US disclosed
EP-4034532-A1 PYRIDONE COMPOUNDS AND METHODS OF USE IN THE MODULATION OF A PROTEIN KINASE Exelixis, Inc. (US) 2022-08-03 EP disclosed
CN-114787144-A Pyridone compounds and methods for modulating protein kinases 埃克塞里艾克西斯公司 2022-07-22 CN disclosed
WO-2021062245-A1 PYRIDONE COMPOUNDS AND METHODS OF USE IN THE MODULATION OF A PROTEIN KINASE EXELIXIS, INC. (US) 2021-04-01 WO disclosed
CN-1055925-A Pyridine derivate and preparation method thereof ICI PLC (GB) 1991-11-06 CN disclosed
US-4744819-A 4-oxo pyridinecarboxamide derivatives as plant growth regulators DAICEL CHEMICAL INDUSTRIES LTD. (JP) 1988-05-17 US disclosed
US-4725306-A Pyridinecarboxamide plant growth inhibitors DAICEL CHEMICAL INDUSTRIES LTD. (JP) 1988-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12371428-B2 Pyridone compounds and methods of use PDXK, PLK2, MAP4K2 NOTUM 2932/4885KDM4E 2816/4885HPGD 695/4885
US-20220315579-A1 PYRIDONE COMPOUNDS AND METHODS OF USE PDXK, PLK2, MAP4K2 NOTUM 2932/4885KDM4E 2816/4885HPGD 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.